# OnCo record idea-cost-indication-based-pricing (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-cost-indication-based-pricing/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-cost-indication-based-pricing" ;
  schema:name "Price a cancer drug by how well it works in each cancer"@en ;
  schema:description "A drug that adds a year of life in one cancer and six weeks in another sells at the same price for both; indication-specific prices would pay for the benefit actually delivered."@en ;
  schema:url <https://onco.cc/ideas/idea-cost-indication-based-pricing/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.esmo.org/guidelines/esmo-mcbs>, <https://doi.org/10.1200/JCO.2016.68.2518> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/atezolizumab/> ;
  onco:institutions <https://onco.cc/institutions/esmo/>, <https://onco.cc/institutions/asco/> ;
  onco:terms <https://onco.cc/terms/icer-value-assessment/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-incentive-misalignment/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-schnipper-j-clin-oncol/> .
